Post-Market Lower Eyelid Treatment With Renuvion in Greece

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

March 5, 2024

Study Completion Date

March 5, 2024

Conditions
Skin Laxity
Interventions
DEVICE

Renuvion APR System

"The Renuvion Generator (K192867) is indicated for delivery of radiofrequency energy and/or helium plasma to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The Renuvion APR Handpiece (K191542) is intended to be used with compatible electrosurgical generators for the delivery of radiofrequency energy and/or helium plasma for cutting, coagulation and ablation of soft tissue during open surgical procedures.~Together, the Renuvion Generator and Handpiece are referred to as the Renuvion APR System."

Trial Locations (1)

15562

Metropolitan General Hospital, Athens

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Apyx Medical

INDUSTRY

NCT05605691 - Post-Market Lower Eyelid Treatment With Renuvion in Greece | Biotech Hunter | Biotech Hunter